|
1）Rudolf Virchow, from Wikipedia. http://en.wikipedia.org/wiki/Rudolf_Virchow
|
|
|
|
|
2）Kwak N, Park CM, Lee J, et al. Lung cancer risk among patients with combined pulmonary fibrosis and emphysema. Respir Med. 2014; 108: 524-30
|
|
|
|
|
3）Hay ED. The mesenchymal cell, its role in the embryo, and the remarkable signaling mechanisms that create it. Dev Dyn. 2005; 233: 706-20
|
|
|
|
|
|
4）Combes AN, Wilhelm D, Davidson T, et al. Endothelial cell migration directs testis cord formation. Dev Biol. 2009; 326: 112-20
|
|
|
|
|
|
5）Morrisey EE, Hogan BL. Preparing for the first breath: genetic and cellular mechanisms in lung development. Dev Cell. 2010; 18: 8-23
|
|
|
|
|
|
6）Morimoto M, Liu Z, Cheng HT, et al. Canonical Notch signaling in the developing lung is required for determination of arterial smooth muscle cells and selection of Clara versus ciliated cell fate. J Cell Sci. 2010; 123: 213-24
|
|
|
|
|
|
7）Hashimoto N, Jin H, Liu T, et al. Bone marrowderived progenitor cells in pulmonary fibrosis. J Clin Invest. 2004; 113: 243-52
|
|
|
|
|
|
8）Kim KK, Kugler MC, Wolters PJ, et al. Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix. Proc Natl Acad Sci U S A. 2006; 103: 13180-5
|
|
|
|
|
|
9）Hashimoto N, Phan SH, Imaizumi K, et al. Endothelial-mesenchymal transition in bleomycin-induced pulmonary fibrosis. Am J Respir Cell Mol Biol. 2010; 43: 161-72
|
|
|
|
|
|
10）LeBleu VS, Taduri G, O’Connell J, et al. Origin and function of myofibroblasts in kidney fibrosis. Nat Med. 2013; 19: 1047-53
|
|
|
|
|
|
11）佐藤光夫，長谷川好規．EMTと肺癌 Surg Front. 2012; 19: 281-90
|
|
|
|
|
|
12）Tischler V, Pfeifer M, Hausladen S, et al. L1CAM protein expression is associated with poor prognosis in non-small cell lung cancer. Mol Cancer. 2011; 10: 127
|
|
|
|
|
|
13）Wu S, Liu S, Liu Z, et al. Classification of circulating tumor cells by epithelial-mesenchymal tra-nsition markers. PLoS One. 2015; 10: e0123976
|
|
|
|
|
|
14）Hashimoto N, Phan SH, Imaizumi K, et al. Endothelial-mesenchymal transition in bleomycin-induced pulmonary fibrosis. Am J Respir Cell Mol Biol. 2011; 45: 684-91
|
|
|
|
|
|
15）Steck PA, Pershouse MA, Jasser SA, et al. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet. 1997; 15: 356-62
|
|
|
|
|
|
16）Rahdar M, Inoue T, Meyer T, et al. A phosphorylation-dependent intramolecular interaction regulates the membrane association and activity of the tumor suppressor PTEN. Proc Natl Acad Sci U S A. 2009; 106: 480-5
|
|
|
|
|
|
17）Sakamoto K, Hashimoto N, Kondoh Y, et al. Differential modulation of surfactant protein D under acute and persistent hypoxia in acute lung injury. Am J Physiol Lung Cell Mol Physiol. 2012; 303: L43-53
|
|
|
|
|
|
18）Aoyama D, Hashimoto N, Sakamoto K, et al. Involvement of TGFβ-induced phosphorylation of the PTEN C-terminus on TGFβ-induced acquisition of malignant phenotypes in lung cancer cells. PLoS One. 2013; 8: e81133
|
|
|
|
|
|
19）Richeldi L, du Bois RM, Raghu G, et al. Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. N Engl J Med. 2014; 370: 2071-82
|
|
|
|
|
|
20）Reck M, Kaiser R, Mellemgaard A, et al. Docetaxel plus nintedanib versus docetaxel plus placebo in patients with previously treated non-small-cell lung cancer（LUME-Lung 1）: a phase 3, double-blind, randomised controlled trial. Lancet Oncol. 2014; 15: 143-55
|
|
|
|
|